UPSC MainsZOOLOGY-PAPER-II202220 Marks
Q28.

What is stem cell? Discuss the types of stem cells and their application in therapeutic uses in human.

How to Approach

This question requires a detailed understanding of stem cells, their classification, and therapeutic applications. The answer should begin with a clear definition of stem cells, followed by a discussion of different types (embryonic, adult, induced pluripotent). For each type, explain its characteristics, source, and potential therapeutic uses. Focus on specific diseases and treatments where stem cells are currently used or showing promise. Structure the answer logically, using headings and subheadings for clarity. Include examples and recent advancements.

Model Answer

0 min read

Introduction

Stem cells are the body’s master cells, possessing the remarkable potential to develop into many different cell types during the early life and growth, as well as to repair damaged tissues. This unique ability, known as pluripotency or multipotency, makes them a subject of intense research and holds immense promise for treating a wide range of diseases and conditions. Recent advancements in induced pluripotent stem cell (iPSC) technology, pioneered by Shinya Yamanaka (Nobel Prize in Physiology or Medicine, 2012), have further expanded the possibilities for regenerative medicine, circumventing many ethical concerns associated with embryonic stem cells. This answer will explore the different types of stem cells and their burgeoning applications in therapeutic interventions.

What are Stem Cells?

Stem cells are undifferentiated biological cells that can divide and differentiate into specialized cell types. They are characterized by two key properties: self-renewal – the ability to divide and create more stem cells – and potency – the capacity to differentiate into different cell types. The potency determines the range of cell types a stem cell can become.

Types of Stem Cells

1. Embryonic Stem Cells (ESCs)

ESCs are derived from the inner cell mass of a blastocyst, an early-stage embryo (typically 3-5 days old). They are pluripotent, meaning they can differentiate into any cell type in the body.

  • Source: Blastocysts created during in-vitro fertilization (IVF) procedures.
  • Advantages: High proliferation rate, unlimited differentiation potential.
  • Disadvantages: Ethical concerns regarding embryo destruction, risk of teratoma formation (tumors containing multiple tissue types), potential for immune rejection.
  • Therapeutic Applications: Potential for treating diseases like Parkinson’s disease, spinal cord injury, type 1 diabetes, and heart disease. Currently, clinical trials are limited due to ethical and safety concerns.

2. Adult Stem Cells (ASCs)

ASCs, also known as somatic stem cells, are found in various tissues throughout the body. They are generally multipotent, meaning they can differentiate into a limited range of cell types specific to their tissue of origin.

  • Source: Bone marrow, adipose tissue, blood, skin, and other tissues.
  • Advantages: Reduced ethical concerns, lower risk of immune rejection (especially if autologous – from the patient’s own body).
  • Disadvantages: Limited differentiation potential, lower proliferation rate compared to ESCs, difficult to isolate and culture.
  • Therapeutic Applications: Hematopoietic stem cell transplantation (HSCT) for treating blood cancers (leukemia, lymphoma) and immune deficiencies is a well-established application. Mesenchymal stem cells (MSCs) from bone marrow are being investigated for treating osteoarthritis, autoimmune diseases, and wound healing.

3. Induced Pluripotent Stem Cells (iPSCs)

iPSCs are adult cells that have been genetically reprogrammed to revert to a pluripotent state, similar to ESCs. This is achieved by introducing specific genes (typically four transcription factors: Oct4, Sox2, Klf4, and c-Myc) into adult cells.

  • Source: Adult cells (e.g., skin cells, blood cells)
  • Advantages: Avoids ethical concerns associated with ESCs, patient-specific iPSCs eliminate the risk of immune rejection, potential for disease modeling and drug screening.
  • Disadvantages: Reprogramming process can be inefficient, potential for genetic instability, risk of tumor formation.
  • Therapeutic Applications: iPSCs are being explored for treating a wide range of diseases, including macular degeneration (retinal pigment epithelium cell replacement), spinal muscular atrophy, and heart failure. Clinical trials are underway for several iPSC-based therapies.

Therapeutic Uses in Humans: A Comparative Overview

Stem Cell Type Potency Source Therapeutic Applications (Examples) Current Status
Embryonic Stem Cells Pluripotent Blastocyst Parkinson’s Disease, Type 1 Diabetes, Spinal Cord Injury Limited clinical trials due to ethical concerns and safety risks.
Adult Stem Cells Multipotent Bone Marrow, Adipose Tissue Hematopoietic Stem Cell Transplantation (Leukemia), Osteoarthritis (MSCs) Well-established for HSCT; MSC therapies are in various stages of clinical trials.
Induced Pluripotent Stem Cells Pluripotent Reprogrammed Adult Cells Macular Degeneration, Spinal Muscular Atrophy, Heart Failure Early-stage clinical trials showing promising results.

Beyond these core applications, stem cell research is also contributing to advancements in disease modeling (creating cell models of diseases to study their mechanisms) and drug discovery (screening potential drugs on stem cell-derived cells).

Conclusion

Stem cell technology represents a revolutionary approach to treating diseases and injuries. While significant challenges remain, including safety concerns, scalability, and cost, the progress made in recent years, particularly with iPSC technology, is remarkable. Continued research and rigorous clinical trials are crucial to unlock the full therapeutic potential of stem cells and translate these promising advancements into effective treatments for a wide range of debilitating conditions. The future of regenerative medicine hinges on overcoming these hurdles and ensuring responsible and ethical development of stem cell therapies.

Answer Length

This is a comprehensive model answer for learning purposes and may exceed the word limit. In the exam, always adhere to the prescribed word count.

Additional Resources

Key Definitions

Potency
The ability of a stem cell to differentiate into different cell types. It ranges from totipotency (can become any cell, including extraembryonic tissues) to pluripotency (can become any cell in the body) to multipotency (can become a limited range of cell types).
Teratoma
A type of tumor that can arise from pluripotent stem cells, containing tissues from all three germ layers (ectoderm, mesoderm, and endoderm). It is a potential safety concern in stem cell therapies.

Key Statistics

The global stem cell market was valued at USD 13.89 billion in 2022 and is projected to reach USD 38.18 billion by 2030, growing at a CAGR of 13.7% from 2023 to 2030.

Source: Grand View Research, 2023 (Knowledge Cutoff: Jan 2023)

As of 2021, over 10,000 stem cell transplants were performed annually in the United States, primarily for hematological malignancies and other blood disorders.

Source: Be The Match, 2021 (Knowledge Cutoff: Jan 2023)

Examples

Treatment of Severe Combined Immunodeficiency (SCID)

SCID, also known as "bubble boy disease," is a genetic disorder where infants lack a functional immune system. HSCT using healthy donor stem cells has been a life-saving treatment for SCID, restoring immune function and allowing children to live normal lives.

Frequently Asked Questions

What is the difference between autologous and allogeneic stem cell transplantation?

Autologous transplantation uses the patient’s own stem cells, minimizing the risk of immune rejection. Allogeneic transplantation uses stem cells from a donor, which carries a risk of graft-versus-host disease (GVHD) where the donor cells attack the patient’s tissues.

Topics Covered

BiologyBiotechnologyMedicineStem Cell TherapyRegenerative MedicineCell Differentiation